Dr. Benedito Carneiro
Claim this profileLifespan Cancer Institute
Studies Cancer
Studies Solid Tumors
11 reported clinical trials
21 drugs studied
Area of expertise
1Cancer
Stage IV
Stage III
NTRK1 positive
2Solid Tumors
Stage IV
Stage III
NTRK1 positive
Affiliated Hospitals
Clinical Trials Benedito Carneiro is currently running
DF6215
for Solid Tumors
This trial tests a modified protein that helps the immune system fight cancer in patients with solid tumors by making it easier for immune cells to find and destroy cancer cells.
Recruiting1 award Phase 110 criteria
TY-2136b
for Solid Tumors
The primary objective of this study is to evaluate the safety and tolerability of TY-2136b and to determine the recommended phase 2 dose (RP2D), with dose-escalation stage and dose-expansion stage.
Recruiting1 award Phase 1
More about Benedito Carneiro
Clinical Trial Related2 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Benedito Carneiro has experience with
- TY-2136b
- Palbociclib Oral Product
- TAS-116
- Nivolumab
- DF6002
- Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitor (TKI)
Breakdown of trials Benedito Carneiro has run
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Benedito Carneiro specialize in?
Benedito Carneiro focuses on Cancer and Solid Tumors. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Benedito Carneiro currently recruiting for clinical trials?
Yes, Benedito Carneiro is currently recruiting for 5 clinical trials in Providence Rhode Island. If you're interested in participating, you should apply.
Are there any treatments that Benedito Carneiro has studied deeply?
Yes, Benedito Carneiro has studied treatments such as TY-2136b, Palbociclib Oral Product, TAS-116.
What is the best way to schedule an appointment with Benedito Carneiro?
Apply for one of the trials that Benedito Carneiro is conducting.
What is the office address of Benedito Carneiro?
The office of Benedito Carneiro is located at: Lifespan Cancer Institute, Providence, Rhode Island 02903 United States. This is the address for their practice at the Lifespan Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.